NO981361L - Syntetiske flervalente sLEX inneholdende polyaktosaminer og anvendelse derav - Google Patents

Syntetiske flervalente sLEX inneholdende polyaktosaminer og anvendelse derav

Info

Publication number
NO981361L
NO981361L NO981361A NO981361A NO981361L NO 981361 L NO981361 L NO 981361L NO 981361 A NO981361 A NO 981361A NO 981361 A NO981361 A NO 981361A NO 981361 L NO981361 L NO 981361L
Authority
NO
Norway
Prior art keywords
polyactosamines
relates
constructs
synthetic polyvalent
slex
Prior art date
Application number
NO981361A
Other languages
English (en)
Other versions
NO981361D0 (no
Inventor
Ossi Renkonen
Risto Renkonen
Original Assignee
Glycim Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycim Oy filed Critical Glycim Oy
Publication of NO981361D0 publication Critical patent/NO981361D0/no
Publication of NO981361L publication Critical patent/NO981361L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører nye blandinger og deres anvendelse ved behandling av inflammatoriske responser. Spesifikt angår oppfinnelsen nye syntetiske oligosakkarid-konstruksjoner og deres anvendelse til å blokkere lymfocyttbinding til tilsvarende oligosakkarider på endoteloverflaten, og således redusere eller på annen måte forbedre en uønsket inflammatorisk respons. Oppfinnelsen angår dessuten anvendelsen av slike konstruksjoner ved andre sykdomstilstanderselektinbinding, så som bakterieinfeksjoner og metastatisk kreft.
NO981361A 1995-09-29 1998-03-25 Syntetiske flervalente sLEX inneholdende polyaktosaminer og anvendelse derav NO981361L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US462395P 1995-09-29 1995-09-29
US786795P 1995-12-01 1995-12-01
PCT/FI1996/000513 WO1997012892A1 (en) 1995-09-29 1996-09-27 SYNTHETIC MULTIVALENT sLEX CONTAINING POLYLACTOSAMINES AND METHODS FOR USE

Publications (2)

Publication Number Publication Date
NO981361D0 NO981361D0 (no) 1998-03-25
NO981361L true NO981361L (no) 1998-05-26

Family

ID=26673254

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981361A NO981361L (no) 1995-09-29 1998-03-25 Syntetiske flervalente sLEX inneholdende polyaktosaminer og anvendelse derav

Country Status (11)

Country Link
US (1) US5965544A (no)
EP (1) EP0874861A1 (no)
JP (1) JP2000507993A (no)
AU (1) AU713078B2 (no)
CA (1) CA2231073A1 (no)
CZ (1) CZ89098A3 (no)
HU (1) HUP9900058A2 (no)
NO (1) NO981361L (no)
PL (1) PL325873A1 (no)
SK (1) SK39498A3 (no)
WO (1) WO1997012892A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
US6841543B1 (en) * 1996-01-31 2005-01-11 President And Fellows Of Harvard College Methods of inhibiting production of T helper type 2 cytokines in human immune cells
JP4179567B2 (ja) * 1996-07-23 2008-11-12 生化学工業株式会社 新規ラクトサミンオリゴ糖およびその製造方法
JP2001515912A (ja) 1997-09-05 2001-09-25 グリシム オサケ ユキチュア 合成二価ｓＬｅｘ含有ポリラクトサミン類および使用法
US7018637B2 (en) * 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
AU2001261534A1 (en) * 2000-05-11 2001-11-20 The Burnham Institute The meca-79 antigen and related methods
DE60139720D1 (de) * 2000-06-28 2009-10-08 Glycofi Inc Verfahren für die Herstellung modifizierter Glykoproteine
AU2001287422A1 (en) * 2000-08-22 2002-03-04 National Research Council Of Canada Synthesis of complex carbohydrates
US20050026866A1 (en) * 2002-08-02 2005-02-03 Pawelek John M. Agents and methods for treatment of disease by oligosaccharide targeting agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
WO1991019501A1 (en) * 1990-06-15 1991-12-26 Cytel Corporation Intercellular adhesion mediators
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5352670A (en) * 1991-06-10 1994-10-04 Alberta Research Council Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
CA2110797C (en) * 1991-06-10 2001-02-20 Andre P. Venot Modified sialyl lewis x compounds
CA2129140A1 (en) * 1992-01-31 1993-08-05 Akira Hasegawa Lewis-type sugar chain derivative
JPH0686684A (ja) * 1992-05-26 1994-03-29 Monsanto Co シアロ抱合体の合成
US5591835A (en) * 1992-06-29 1997-01-07 Glycomed Incorporated Substituted lactose derivatives
US5426178A (en) * 1993-03-31 1995-06-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis of anti-inflammatory compounds, and novel trisaccharides useful in the synthesis of anti-inflammatory compounds
JPH08509720A (ja) * 1993-05-03 1996-10-15 ジェネンテク、インコーポレイテッド 白血球接着阻害
US5374541A (en) * 1993-05-04 1994-12-20 The Scripps Research Institute Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
US5409817A (en) * 1993-05-04 1995-04-25 Cytel, Inc. Use of trans-sialidase and sialyltransferase for synthesis of sialylα2→3βgalactosides
CN1125449A (zh) * 1993-05-14 1996-06-26 萨依特尔有限公司 作为细胞粘附抑制剂的唾液基Lex类似物
WO1995001361A1 (fr) * 1993-07-02 1995-01-12 Nippon Shinyaku Co., Ltd. Derive de galactosylmoranoline
US5559103A (en) * 1993-07-21 1996-09-24 Cytel Corporation Bivalent sialyl X saccharides
AU7467394A (en) * 1993-08-23 1995-03-21 Nippon Shinyaku Co. Ltd. Galactosylmoranoline derivative
EP0671409A3 (de) * 1994-03-11 1996-06-12 Hoechst Ag Malonsäurederivate mit antiadhäsiven Eigenschaften.
HUT77345A (hu) * 1994-04-29 1998-03-30 Texas Biotechnology Corporation E-szelektin, P-szelektin vagy L-szelektin szialil-Lewis x-hez vagy szialil-Lewis a-hoz kapcsolódását gátló mannopiranoziloxi-bifenil származékok és ezeket tartalmazó gyógyszerkészítmények

Also Published As

Publication number Publication date
SK39498A3 (en) 1999-01-11
CZ89098A3 (cs) 1998-09-16
EP0874861A1 (en) 1998-11-04
US5965544A (en) 1999-10-12
AU7087296A (en) 1997-04-28
WO1997012892A1 (en) 1997-04-10
NO981361D0 (no) 1998-03-25
AU713078B2 (en) 1999-11-25
PL325873A1 (en) 1998-08-17
JP2000507993A (ja) 2000-06-27
CA2231073A1 (en) 1997-04-10
HUP9900058A2 (hu) 1999-04-28

Similar Documents

Publication Publication Date Title
NO981361L (no) Syntetiske flervalente sLEX inneholdende polyaktosaminer og anvendelse derav
DE69702911T2 (de) Oxydierte oligosaccharide
MEP48408A (en) Anti-tnf antibodies, compositions, methods and uses
DK0699104T3 (da) Fremgangsmåde til underkritisk tørring af aerogeler
NO980881L (no) Fremgangsmater og blandinger for selektiv modifikasjon av nukleinsyrer
KR850008282A (ko) 그람음성균상의 혈청형 리포다당류 결정인자에 대한 인체 단크론(monoclonal)항체와 그 제조방법
CA2418961A1 (en) Anti-il-12 antibodies, compositions, methods and uses
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
PT1017692E (pt) 4-heteroaril-tetrahidroquinolinas e sua aplicacao como inibidores da proteina de transferencia de ester de colesterol (ctep)
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
Ho et al. Identification of Streptococcus cristatus peptides that repress expression of virulence genes in Porphyromonas gingivalis
RU95109161A (ru) Присадки и добавки к нефтепродуктам
NO974564D0 (no) Karbohydratmodifiserte cytostatika
KR950031099A (ko) 유산균 함유 사하약 조성물
KR870002826A (ko) 퍼어머넌트 웨이브 용제
FI931714A (fi) Fukthaerdbar en-komponent polysiloxanfoerening
NO20001091L (no) Syntetisk divalent sLex inneholdende polylaktosaminer og fremgangsmåter for anvendelse
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
FI102078B1 (fi) Alkoholeja lohkaisemalla elastomeereiksi verkkoutettavat organo(poly)siloksaanimassat
ATE176898T1 (de) Fliessfähigkeitregelung von zementzusammensetzungen
FI962323A0 (fi) N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit
FI963289A (fi) Öljykoostumukset
WO1999047558A3 (en) T cell costimulatory proteins, sequences and uses thereof
WO1994025598A3 (en) Methods and compositions for salmonella-based vaccines
DK1051491T3 (da) Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application